Search

everythinglearnresearchcommunity

for

Search:↓

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

Fluorescent proteins help visualize and understand tumor blood vessel growth.

The ACTH/MC2R system is crucial for controlling hair growth cycles in mice.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Concentrated growth factor shows promise for treating hair loss but needs more research.

Ganoderma lucidum extract can potentially reduce stress-induced hair loss by slowing down premature hair aging and removing harmful substances.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Rhodamin B stain is inconsistent for keratin in skin samples.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

A rare case of Cushing syndrome was successfully treated with one-sided adrenal gland removal, suggesting personalized treatment is important.

Keratinocyte growth factor significantly alters skin and tissue development.

Higher homocysteine levels may inhibit hair growth and are linked to androgenetic alopecia.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

S100A3 protein is mainly found in specific parts of human hair cells.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

Metformin lowers gremlin-1 and improves insulin resistance in women with PCOS.

A cat's hair loss was linked to a severe pancreatic cancer.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Ectopic adrenal rests can cause androgen excess after adrenalectomy and may need targeted surgery.

Skin RAGE levels are linked to inflammation and cell death.

MCSP may help identify and regulate skin stem cells, affecting hair growth and regeneration.

A toddler with a rare adrenal gland tumor causing male-like physical changes was successfully treated with surgery.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Targeting EGFR may help reduce hair loss from chemotherapy.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

The inhibitor affects androgen metabolism but not ovarian function.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.